These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11489323)

  • 1. Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin.
    Sakuma S; Lu ZR; Kopecková P; Kopecek J
    J Control Release; 2001 Aug; 75(3):365-79. PubMed ID: 11489323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer.
    Gao SQ; Lu ZR; Petri B; Kopečková P; Kopeček J
    J Control Release; 2006 Jan; 110(2):323-331. PubMed ID: 16290118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.
    Gao SQ; Lu ZR; Kopecková P; Kopecek J
    J Control Release; 2007 Feb; 117(2):179-85. PubMed ID: 17150276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.
    Gao SQ; Sun Y; Kopecková P; Peterson CM; Kopecek J
    Pharm Res; 2008 Jan; 25(1):218-26. PubMed ID: 17929146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of novel bioconjugates for targeted drug delivery.
    Lu ZR; Shiah JG; Sakuma S; Kopecková P; Kopecek J
    J Control Release; 2002 Jan; 78(1-3):165-73. PubMed ID: 11772458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts.
    Gao SQ; Sun Y; Kopecková P; Peterson CM; Kopecek J
    Macromol Biosci; 2009 Nov; 9(11):1135-42. PubMed ID: 19685500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates.
    Lu ZR; Gao SQ; Kopecková P; Kopecek J
    Bioconjug Chem; 2000; 11(1):3-7. PubMed ID: 10639078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
    Omelyanenko V; Gentry C; Kopecková P; Kopecek J
    Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
    Tijerina M; Kopecková P; Kopecek J
    Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L; Zhou M; Huang Y
    Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
    Tijerina M; Kopecková P; Kopecek J
    Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
    Gianasi E; Wasil M; Evagorou EG; Keddle A; Wilson G; Duncan R
    Eur J Cancer; 1999 Jun; 35(6):994-1002. PubMed ID: 10533484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
    Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
    David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
    Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
    Line BR; Mitra A; Nan A; Ghandehari H
    J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F
    J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
    Li L; Yang Q; Zhou Z; Zhong J; Huang Y
    Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of disulfide-linked HPMA copolymer-mesochlorin e6 conjugates.
    Cuchelkar V; Kopecková P; Kopecek J
    Macromol Biosci; 2008 May; 8(5):375-83. PubMed ID: 18215003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.